Acknowledgement
Supported by : Korea Health Industry Development Institute (KHIDI)
References
- Bravo EL. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 1994;15:356-68. https://doi.org/10.1210/edrv-15-3-356
- Plouin PF and Gimenez-Roqueplo AP. Pheochromocytomas and secreting paragangliomas. Orphanet J Rare Dis 2006;1:49. https://doi.org/10.1186/1750-1172-1-49
- Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 2007;3:92-102. https://doi.org/10.1038/ncpendmet0396
- Eisenhofer G, Goldstein DS, Kopin IJ, Crout JR. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor. Endocr Pathol 2003;14:193-212. https://doi.org/10.1007/s12022-003-0012-4
- Sawka AM, Jaeschke R, Singh RJ, Young WF Jr. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 2003;88:553-8. https://doi.org/10.1210/jc.2002-021251
- Peaston RT, Graham KS, Chambers E, van der Molen JC, Ball S. Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma. Clin Chim Acta 2010;411:546-52. https://doi.org/10.1016/j.cca.2010.01.012
- Grossman A, Pacak K, Sawka A, Lenders JW, Harlander D, Peaston RT, et al. Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? Ann N Y Acad Sci 2006;1073:332-47. https://doi.org/10.1196/annals.1353.038
- Singh RJ and Eisenhofer G. High-throughput, automated, and accurate biochemical screening for pheochromocytoma: are we there yet? Clin Chem 2007;53:1565-7. https://doi.org/10.1373/clinchem.2007.089128
- Sawka AM, Gafni A, Thabane L, Young WF Jr. The economic implications of three biochemical screening algorithms for pheochromocytoma. J Clin Endocrinol Metab 2004;89:2859-66. https://doi.org/10.1210/jc.2003-031127
- Eisenhofer G, Siegert G, Kotzerke J, Bornstein SR, Pacak K. Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas. Horm Metab Res 2008;40:329-37. https://doi.org/10.1055/s-2008-1073156
- de Jong WH, Graham KS, van der Molen JC, Links TP, Morris MR, Ross HA, et al. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry. Clin Chem 2007;53:1684-93. https://doi.org/10.1373/clinchem.2007.087114
- Lagerstedt SA, O’Kane DJ, Singh RJ. Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma. Clin Chem 2004;50:603-11. https://doi.org/10.1373/clinchem.2003.024703
- Trufelli H, Palma P, Famiglini G, Cappiello A. An overview of matrix effects in liquid chromatography-mass spectrometry. Mass Spectrom Rev 2011;30:491-509. https://doi.org/10.1002/mas.20298
Cited by
- A simple and robust liquid chromatography tandem mass spectrometry assay for determination of plasma free metanephrines and its application to routine clinical testing for diagnosis of pheochromocytom vol.33, pp.10, 2015, https://doi.org/10.1002/bmc.4622
- Quantitative Measurement of Plasma Free Metanephrines by a Simple and Cost-Effective Microextraction Packed Sorbent with Porous Graphitic Carbon and Liquid Chromatography-Tandem Mass Spectrometry vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/8821276
- Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma vol.36, pp.3, 2015, https://doi.org/10.3803/enm.2020.925
- Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part I-Development vol.42, pp.2, 2015, https://doi.org/10.3343/alm.2022.42.2.121